Skye Bioscience, Inc.SKYENASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average, modest growth trend.
Left:
||||
Year-over-year research & development expense growth
Latest
221.36%
↑ 102% above average
Average (9y)
109.40%
Historical baseline
Range
High:577.65%
Low:-66.85%
CAGR
+4.2%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 221.36% |
| 2023 | -3.20% |
| 2022 | 105.08% |
| 2021 | 50.79% |
| 2020 | -13.06% |
| 2019 | 577.65% |
| 2018 | 6.00% |
| 2017 | -66.85% |
| 2016 | 63.00% |
| 2015 | 153.23% |